Neoantigenics is Drug Discovery in United States that focus on developer business. Founded in 2012. They cover business area such as developer, therapeutic and diagnostic product, urogenital tract cancer, oocyte associate cancer protein, antibody-drug conjugate therapeutic, neoantigen, patient, treatment, ovarian, uterine, bladder and renal cancer.
2012
( 12 years old in 2024 )
Developer
-
1000 Research Park Boulevard
Suite 103
Charlottesville, VA 22911
United States
Private
developertherapeutic and diagnostic producturogenital tract canceroocyte associate cancer proteinantibody-drug conjugate therapeuticneoantigenpatienttreatmentovarian, uterine, bladder and renal cancer
* We use standard office opening hours in near Neoantigenics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Neoantigenics is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), Neoantigenics business is focusing on Developer.
Neoantigenics headquarter office and corporate office address is located in 1000 Research Park Boulevard Suite 103 Charlottesville, VA 22911 United States.
Neoantigenics was founded in United States.
In 2024, Neoantigenics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Neoantigenics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
